Zhujiang Dai
Overview
Explore the profile of Zhujiang Dai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding W, Dai Z, Cui L, Wu X, Zhou W, Ding Z, et al.
Int J Colorectal Dis
. 2025 Feb;
40(1):38.
PMID: 39945848
Background: Total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is widely regarded as a definitive surgical option for managing ulcerative colitis (UC). Enhanced recovery programs (ERP) have shown potential in better...
2.
Dai X, Li Y, Wang H, Dai Z, Chen Y, Liu Y, et al.
Front Oncol
. 2024 Oct;
14:1402847.
PMID: 39464705
Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are the predominant serum tumour markers (STMs) for predicting the prognosis of colorectal cancer (CRC). The objective of this research is...
3.
Shen X, Peng X, Guo Y, Dai Z, Cui L, Yu W, et al.
Elife
. 2024 Jul;
12.
PMID: 39046443
The role of processing bodies (P-bodies) in tumorigenesis and tumor progression is not well understood. Here, we showed that the oncogenes YAP/TAZ promote P-body formation in a series of cancer...
4.
Dai X, Dai Z, Fu J, Liang Z, Du P, Wu T
World J Surg Oncol
. 2024 Jul;
22(1):186.
PMID: 39030562
Background: Microsatellite instability-high (MSI-H) tumors, with elevated tumor mutational burden and expression of neoantigens, represent a distinct immune-activated subpopulation in colorectal cancer (CRC), characterized by strong lymph node reaction, locally...
5.
Dang X, Chen X, Liang Z, Dai Z, Ding W, Song J, et al.
Cancer Biol Ther
. 2024 Jun;
25(1):2361594.
PMID: 38857058
P4HA2 has been implicated in various malignant tumors; however, its expression and functional role in colorectal cancer (CRC) remain poorly elucidated. This study aims to investigate the involvement of P4HA2...
6.
Dai Z, Peng X, Cui X, Guo Y, Zhang J, Shen X, et al.
J Cancer Res Clin Oncol
. 2023 Jul;
149(14):13087-13106.
PMID: 37474678
Purpose: Colon cancer is highly heterogeneous in terms of the immune and stromal microenvironment, genomic integrity, and oncogenic properties; therefore, molecular subtypes of the four characteristic dimensions are expected to...
7.
Dai Z, Xu W, Ding R, Peng X, Shen X, Song J, et al.
Front Public Health
. 2023 Jun;
11:1151837.
PMID: 37304119
Introduction: Over the past few years, multiple observational studies have speculated a potential association between inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), and osteoporosis....
8.
Dai Z, Zhang J, Xu W, Du P, Wang Z, Liu Y
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047025
Crohn's disease is a highly heterogeneous autoimmune disease with a unique inflammatory phenotype of T cells at the lesion site. We aim to further explore the diagnosis of Crohn's disease...
9.
Dai Z, Fu J, Peng X, Tang D, Song J
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230724
In recent years, cancer immunotherapy has become a breakthrough method to solve solid tumors. It uses immune checkpoint inhibitors to interfere with tumor immune escape to coordinate anti-tumor therapy. However,...
10.
Dai Z, Peng X, Guo Y, Shen X, Ding W, Fu J, et al.
J Cancer Res Clin Oncol
. 2022 Jun;
149(6):2393-2416.
PMID: 35731273
Purpose: Colon cancer presents challenges to clinical diagnosis and management due to its high heterogeneity. For more efficient and convenient diagnosis and treatment of colon cancer, we are committed to...